FDA Warning Letter — Homeolab USA Inc.
The FDA took a Warning Letter action against Homeolab USA Inc. on August 2, 2017 (Montreal, Canada). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Homeolab USA Inc.
- Date
- August 2, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Montreal (Canada)